Grossman William 4
4 · Arcus Biosciences, Inc. · Filed Dec 18, 2020
Insider Transaction Report
Form 4
Grossman William
Chief Medical Officer
Transactions
- Sale
Common Stock
2020-12-16$31.35/sh−2,117$66,368→ 6,727 total
Footnotes (2)
- [F1]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant.
- [F2]Includes 992 shares purchased on 5/29/2020 and 1,002 shares purchased on 11/30/2020 through the Company's Employee Stock Purchase Plan.